Pulled in March after it turned up in wild fish, now asked for again: doctors want antibiotic resistance weighed before Tasmania’s salmon farms get florfenicol back
The Australian Medical Association has urged the national regulator to assess the human health risk of antibiotic resistance before it decides whether Tasmania's salmon farms can use the antibiotic florfenicol again. The last emergency permit was revoked in March after traces were found in wild fish near the farms; the industry has asked for a new one on the same terms, and a decision could come within days.
Three things to know
- Salmon Tasmania wants a new emergency permit for florfenicol at the same dose and frequency as the one revoked in March 2026.
- The AMA calls antimicrobial resistance one of the most serious health threats of the century and wants independent risk assessments made public.
- Tasmanian health advice is to avoid eating wild finfish caught within 3km of a treated lease for 21 days after treatment.
Eight months after the national regulator pulled the permit over residues found in wild fish, Tasmania’s salmon industry is asking to use the antibiotic florfenicol again, and Australia’s doctors want a harder look first.
The Australian Medical Association (AMA) has called on the Australian Pesticides and Veterinary Medicines Authority (APVMA) to fully assess the health and environmental risks of antibiotic resistance before it rules on Salmon Tasmania’s application. The AMA described antimicrobial resistance as one of “the most serious global health threats of the 21st century” and said the regulator should not keep granting emergency permits. It wants independent environmental and human health risk evaluations published.
A decision is expected as early as this week.
What is florfenicol, and why do salmon farms want it?
Florfenicol is a veterinary antibiotic. It is not used to treat infections in people in Australia. The salmon industry says it is the preferred treatment for Piscirickettsia salmonis, the bacterium behind a disease outbreak that killed large numbers of farmed fish in Tasmania’s south-east in early 2025.
The APVMA first allowed it under an emergency permit in November 2025 for the south-eastern biosecurity zone. Fish were dosed at 10 to 20 milligrams per kilogram of body weight a day for 10 consecutive days, with no re-treatment.
Why was the permit revoked?
Testing found traces of the antibiotic in wild fish caught near the salmon pens, and later in abalone. The APVMA revoked the permit, citing an “unacceptable risk of residue exposure” to animals the drug was never meant to reach. The suspension took effect on 4 March 2026.
Salmon Tasmania’s new application asks for the same dose rates and treatment frequency as the revoked permit. Public submissions closed on Monday 16 November. The APVMA is separately weighing a minor-use permit sought by the drug’s manufacturer, Abbey Labs, which a Senate estimates hearing in October heard would use higher doses across both the south-eastern and eastern zones.
What do the farmers say?
Salmon Tasmania chief executive John Whittington said the industry agreed with the AMA that antibiotic resistance is a serious global issue. “There is no routine or preventative antibiotic use in Tasmanian salmon farming,” he said. He said vaccines and selective breeding are being developed quickly and that the industry expects its need for antibiotics to fall close to zero.
Is Tasmanian salmon safe to eat?
The Tasmanian Health Department says there have been no reports of harm to human health from florfenicol residues in seafood. Its standing advice for recreational fishers is to avoid eating wild finfish caught within 3km of a lease where fish are being treated, for 21 days after treatment ends. Anyone with specific health concerns should talk to their doctor.
The worry doctors raise is less about a single meal and more about the bigger picture. Every time antibiotics are used in large quantities, in people, livestock or fish, bacteria have more chances to evolve resistance, and resistant genes can move between species of bacteria. That is why the AMA wants the decision judged on human health as well as fish health.
Why does this matter beyond Tasmania?
Tasmanian salmon is on supermarket shelves and restaurant menus across the country, and salmon farming is one of Tasmania’s major industries. How the regulator handles this application will signal how far Australia is prepared to go in using antibiotics to keep a food industry running through disease outbreaks, and how much weight it gives to the long-term risk of drugs that stop working.
The pressure on Tasmania’s waters is not only about florfenicol. The state’s Environment Department has closed commercial rock lobster and dive fisheries in parts of the south-east for three months to manage trade risks linked to the use of another antibiotic, oxytetracycline, in salmon farms.
How we got here
The key moments that brought this story into focus. Open any moment for detail.
Early 2025Disease outbreak
A bacterial disease kills large numbers of farmed salmon in Tasmania's south-east.
November 2025Emergency permit
The APVMA allows florfenicol under an emergency permit in the south-eastern zone.
4 March 2026Permit revoked
The APVMA suspends the permit over residues found in wild fish.
October 2026Senate estimates
A hearing is told of a separate manufacturer application at higher doses.
16 November 2026Submissions close
Public comment ends on Salmon Tasmania's new emergency permit request.
22 November 2026AMA intervenes
Doctors urge the regulator to weigh antibiotic resistance before deciding.
What happens next
The APVMA is expected to decide on Salmon Tasmania's emergency permit request as early as this week. The separate Abbey Labs minor-use application is still under assessment. The AMA wants any approval accompanied by published independent risk assessments.
Sources
- VNN
VNN never names people who give us information in confidence. How we protect sources and tips.
That is the story in a minute. For the evidence, context and what happens next, switch to the full story.
Weather today
Sunday 22 November
Perth
Mild with rain nearby · 18% rain
20°15°
Sydney heats to 30 and Melbourne 28 while Perth stays mild; rain soaks Paris and New York, and storms build over Sao Paulo.
- Sydney30°19°
- Melbourne28°15°
- Brisbane26°18°
- Adelaide26°17°
- Auckland19°13°
- Singapore30°25°
More cities (13)
- Tokyo13°6°
- Hong Kong21°17°
- Mumbai30°21°
- Dubai31°20°
- Nairobi23°16°
- Lagos30°26°
- Johannesburg28°18°
- London8°5°
- Paris8°7°
- New York14°10°
- Los Angeles18°11°
- Toronto13°5°
- Sao Paulo32°22°
Highs and lows in °C, local time.
Breaking now
Live deskDeveloping stories
Live deskStories we’re following
Live deskMost read this week
For subscribers
Read every subscriber story in full, on any device. Premium reports are sold separately.
Secure payment · Cancel anytime · Subscribers sign in
Markets
Stocks
- Alphabet (GOOGL)Nasdaq265.29 USDdown -2.70%
- Amazon (AMZN)Nasdaq246.82 USDdown -4.10%
- Apple (AAPL)Nasdaq342.56 USDdown -1.90%
- ASX 200ASX8,730down -1.04%
- Berkshire Hathaway (BRK.B)NYSE570.00 USDdown -0.36%
- BHP Group (BHP)ASX51.40 AUDdown -1.80%
Currencies
- AUD/EURForex0.607100 EURdown -0.31%
- AUD/GBPForex0.508500 GBPup +0.02%
- AUD/JPYForex106.1100 JPYdown -0.41%
- AUD/NZDForex1.212700 NZDdown -0.18%
- AUD/USDForex0.666600 USDdown -0.16%
- BTC/USDCrypto58,970.00 USDdown -5.21%
As at 21 Nov 2026, 6:40 am GMT+0800. Entered by VNN. Not financial advice.
For you
Follow the topics you care about and save stories with the bookmark. They gather here, on this device only.
Saved on this device only. Nothing is sent to VNN.
Help keep the lights on.
Independent news costs money to make and nothing to read. Chip in and keep it that way.
ContributeFrom A$5 a month · Cancel anytimeThe daily briefing
Start informed.
The essential headlines, the useful context and what to watch next, in your inbox each morning.







Comments
0 commentsCommunity rules
To read and join the conversation, please agree to our rules.
You have agreed to the community rules.
No comments yet. Start the conversation.